BNP Paribas Asset Management
IMGN

BNP Paribas Asset Management’s Immunogen Inc IMGN Stock Holding History

BNP Paribas Asset Management’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-1,038,616
Closed -$4.66M – 940
2018
Q4 		$4.66M Buy
1,038,616
+100,781
+11% +$612K 0.04% 459
2018
Q3 		$8.88M Buy
+937,835
New +$9.02M 0.07% 361

Other funds holding IMGN

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BNP Paribas Asset Management's IMGN Position: Q1 2019 in Review

BNP Paribas Asset Management sold out of Immunogen Inc (IMGN) in Q1 2019, closing a stake of 1,038,616 shares — an estimated $4.66M sold.

BNP Paribas Asset Management first reported a position in IMGN in Q3 2018 and held it in 2 quarters. The position peaked at $8.88M in Q3 2018. 212 funds tracked by Wall St. Rank hold IMGN as of Q1 2019.

  • BNP Paribas Asset Management reported no remaining Immunogen Inc position as of Q1 2019 after selling out during the quarter.
  • BNP Paribas Asset Management sold 1,038,616 Immunogen Inc shares in Q1 2019, an estimated $4.66M.
  • BNP Paribas Asset Management first reported a position in Immunogen Inc in Q3 2018 and held it in 2 quarters.
  • BNP Paribas Asset Management's Immunogen Inc position peaked at $8.88M in Q3 2018.
  • 212 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2019.

Based on BNP Paribas Asset Management's 13F filing for Q1 2019, filed 26 Apr 2019.